Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer. (Record no. 26105894)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01587 a2200421 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517101116.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0893-9675 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1615/CritRevOncog.v20.i5-6.120 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wang, Justin Q |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180130 |
| 245 00 - TITLE STATEMENT | |
| Title | Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Critical reviews in oncogenesis |
| Date of publication, distribution, etc. | 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 407-17 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Extracellular Vesicles |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Paclitaxel |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostatic Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Signal Transduction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Taxoids |
| General subdivision | therapeutic use |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | DeChalus, Austin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chatterjee, Devin N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Keller, Evan T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mizokami, Atsushi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Camussi, Giovanni |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mendelsohn, Andrew R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Renzulli Ii, Joseph F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Quesenberry, Peter J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chatterjee, Devasis |
| 773 0# - HOST ITEM ENTRY | |
| Title | Critical reviews in oncogenesis |
| Related parts | vol. 20 |
| -- | no. 5-6 |
| -- | p. 407-17 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1615/CritRevOncog.v20.i5-6.120">https://doi.org/10.1615/CritRevOncog.v20.i5-6.120</a> |
| Public note | Available from publisher's website |
No items available.